ALXN
Goldman Sachs’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-781,412
| Closed | -$144M | – | 5738 |
|
2021
Q2 | $144M | Buy |
781,412
+119,633
| +18% | +$22M | 0.03% | 467 |
|
2021
Q1 | $101M | Sell |
661,779
-108,377
| -14% | -$16.6M | 0.03% | 573 |
|
2020
Q4 | $120M | Sell |
770,156
-716,030
| -48% | -$112M | 0.03% | 454 |
|
2020
Q3 | $170M | Buy |
1,486,186
+191,823
| +15% | +$22M | 0.05% | 338 |
|
2020
Q2 | $145M | Sell |
1,294,363
-34,096
| -3% | -$3.83M | 0.04% | 373 |
|
2020
Q1 | $119M | Sell |
1,328,459
-1,759,846
| -57% | -$158M | 0.04% | 415 |
|
2019
Q4 | $334M | Buy |
3,088,305
+583,774
| +23% | +$63.1M | 0.09% | 221 |
|
2019
Q3 | $245M | Buy |
2,504,531
+323,720
| +15% | +$31.7M | 0.07% | 280 |
|
2019
Q2 | $286M | Buy |
2,180,811
+684,850
| +46% | +$89.7M | 0.08% | 218 |
|
2019
Q1 | $202M | Sell |
1,495,961
-151,257
| -9% | -$20.4M | 0.06% | 325 |
|
2018
Q4 | $160M | Sell |
1,647,218
-444,048
| -21% | -$43.2M | 0.05% | 364 |
|
2018
Q3 | $291M | Sell |
2,091,266
-342,897
| -14% | -$47.7M | 0.08% | 249 |
|
2018
Q2 | $302M | Sell |
2,434,163
-29,083
| -1% | -$3.61M | 0.08% | 220 |
|
2018
Q1 | $275M | Sell |
2,463,246
-1,681,190
| -41% | -$187M | 0.07% | 278 |
|
2017
Q4 | $496M | Buy |
4,144,436
+686,209
| +20% | +$82.1M | 0.12% | 143 |
|
2017
Q3 | $485M | Sell |
3,458,227
-1,343,647
| -28% | -$189M | 0.12% | 120 |
|
2017
Q2 | $584M | Buy |
4,801,874
+3,237,464
| +207% | +$394M | 0.15% | 89 |
|
2017
Q1 | $190M | Buy |
1,564,410
+434,644
| +38% | +$52.7M | 0.05% | 345 |
|
2016
Q4 | $138M | Sell |
1,129,766
-935,906
| -45% | -$115M | 0.04% | 469 |
|
2016
Q3 | $253M | Buy |
2,065,672
+616,476
| +43% | +$75.5M | 0.08% | 211 |
|
2016
Q2 | $169M | Buy |
1,449,196
+515,000
| +55% | +$60.1M | 0.06% | 342 |
|
2016
Q1 | $130M | Sell |
934,196
-427,874
| -31% | -$59.6M | 0.04% | 456 |
|
2015
Q4 | $260M | Buy |
1,362,070
+217,900
| +19% | +$41.6M | 0.08% | 202 |
|
2015
Q3 | $179M | Sell |
1,144,170
-274,886
| -19% | -$43M | 0.06% | 276 |
|
2015
Q2 | $257M | Buy |
1,419,056
+900,791
| +174% | +$163M | 0.08% | 212 |
|
2015
Q1 | $89.8M | Sell |
518,265
-44,056
| -8% | -$7.63M | 0.03% | 559 |
|
2014
Q4 | $104M | Sell |
562,321
-121,403
| -18% | -$22.5M | 0.03% | 496 |
|
2014
Q3 | $113M | Sell |
683,724
-176,008
| -20% | -$29.2M | 0.04% | 439 |
|
2014
Q2 | $134M | Sell |
859,732
-226,683
| -21% | -$35.4M | 0.04% | 412 |
|
2014
Q1 | $165M | Buy |
1,086,415
+10,433
| +1% | +$1.59M | 0.05% | 312 |
|
2013
Q4 | $143M | Sell |
1,075,982
-22,198
| -2% | -$2.95M | 0.05% | 345 |
|
2013
Q3 | $128M | Sell |
1,098,180
-209,991
| -16% | -$24.4M | 0.05% | 354 |
|
2013
Q2 | $121M | Buy |
+1,308,171
| New | +$121M | 0.05% | 345 |
|